Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
22
NMPA:22
Drug Approvals
Levodropropizine Oral Solution
- Product Name
- 左羟丙哌嗪口服溶液
- Approval Number
- 国药准字H20193049
- Approval Date
- Sep 11, 2024
NMPA
Paracetamol Oral Solution
- Product Name
- 对乙酰氨基酚口服溶液
- Approval Number
- 国药准字H20093620
- Approval Date
- Nov 29, 2023
NMPA
Dexibuprofen Oral Suspension
- Product Name
- 右旋布洛芬口服混悬液
- Approval Number
- 国药准字H20233616
- Approval Date
- Aug 2, 2023
NMPA
Cetirizine Hydrochloride Oral Solution
- Product Name
- 盐酸西替利嗪口服溶液
- Approval Number
- 国药准字H20093320
- Approval Date
- Jun 29, 2023
NMPA
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Tablets
- Product Name
- 氨溴特罗片
- Approval Number
- 国药准字H20080487
- Approval Date
- Apr 13, 2023
NMPA
Risperidone Oral Solution
- Product Name
- 利培酮口服液
- Approval Number
- 国药准字H20183210
- Approval Date
- Mar 23, 2023
NMPA
Levocetirizine Dihydrochloride Oral Solution
- Product Name
- 盐酸左西替利嗪口服溶液
- Approval Number
- 国药准字H20183008
- Approval Date
- Dec 8, 2022
NMPA
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20073956
- Approval Date
- Jun 28, 2022
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found